Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Manhattan Associates, Inc is a software—application business based in the US. Manhattan Associates shares (MANH) are listed on the NASDAQ and all prices are listed in US Dollars. Manhattan Associates employs 3,500 staff and has a trailing 12-month revenue of around USD$592.2 million.
Since the stock market crash in March caused by coronavirus, Manhattan Associates's share price has had significant positive movement.
Its last market close was USD$93.47, which is 17.49% up on its pre-crash value of USD$77.12 and 165.54% up on the lowest point reached during the March crash when the shares fell as low as USD$35.2.
If you had bought USD$1,000 worth of Manhattan Associates shares at the start of February 2020, those shares would have been worth USD$488.85 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,072.10.
|Latest market close||USD$93.47|
|52-week range||USD$35.2 - USD$106.17|
|50-day moving average||USD$95.3018|
|200-day moving average||USD$93.0098|
|Wall St. target price||USD$116.2|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.299|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-23)||-3.30%|
|1 month (2020-10-30)||9.32%|
|3 months (2020-08-28)||-5.84%|
|6 months (2020-05-29)||5.74%|
|1 year (2019-11-29)||11.93%|
|2 years (2018-11-30)||88.71%|
|3 years (2017-11-30)||110.76%|
|5 years (2015-11-30)||22.02%|
Valuing Manhattan Associates stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Manhattan Associates's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Manhattan Associates's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 77x. In other words, Manhattan Associates shares trade at around 77x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Manhattan Associates's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.0009. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Manhattan Associates's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Manhattan Associates's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$120 million.
The EBITDA is a measure of a Manhattan Associates's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$592.2 million|
|Operating margin TTM||18.73%|
|Gross profit TTM||USD$333 million|
|Return on assets TTM||17.39%|
|Return on equity TTM||49.15%|
|Market capitalisation||USD$6.3 billion|
TTM: trailing 12 months
There are currently 2.5 million Manhattan Associates shares held short by investors – that's known as Manhattan Associates's "short interest". This figure is 1.7% up from 2.4 million last month.
There are a few different ways that this level of interest in shorting Manhattan Associates shares can be evaluated.
Manhattan Associates's "short interest ratio" (SIR) is the quantity of Manhattan Associates shares currently shorted divided by the average quantity of Manhattan Associates shares traded daily (recently around 374320.82066869). Manhattan Associates's SIR currently stands at 6.58. In other words for every 100,000 Manhattan Associates shares traded daily on the market, roughly 6580 shares are currently held short.
However Manhattan Associates's short interest can also be evaluated against the total number of Manhattan Associates shares, or, against the total number of tradable Manhattan Associates shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Manhattan Associates's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Manhattan Associates shares in existence, roughly 40 shares are currently held short) or 0.0496% of the tradable shares (for every 100,000 tradable Manhattan Associates shares, roughly 50 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Manhattan Associates.
Find out more about how you can short Manhattan Associates stock.
We're not expecting Manhattan Associates to pay a dividend over the next 12 months.
Manhattan Associates's shares were split on a 4:1 basis on 13 January 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Manhattan Associates shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Manhattan Associates shares which in turn could have impacted Manhattan Associates's share price.
Over the last 12 months, Manhattan Associates's shares have ranged in value from as little as $35.2 up to $106.17. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Manhattan Associates's is 1.9701. This would suggest that Manhattan Associates's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Manhattan Associates, Inc. develops, sells, deploys, services, and maintains software solutions to manage supply chains, inventory, and omni-channel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. The company offers Manhattan SCALE, a portfolio of logistics execution solutions that provide trading partner management, yard management, optimization, warehouse management, and transportation execution services; and Manhattan Active, a set of enterprise and store omni-channel solutions. It also provides inventory optimization and planning solutions; maintenance services comprising customer support services and software enhancements; professional services, such as solutions planning and implementation, and related consulting services; and training and change management services. In addition, the company resells computer hardware, radio frequency terminal networks, radio frequency identification chip readers, bar code printers and scanners, and other peripherals. It offers products through direct sales personnel, as well as through partnership agreements with various organizations. The company operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Manhattan Associates, Inc. was founded in 1990 and is headquartered in Atlanta, Georgia.
Everything we know about the Sabic IPO, plus information on how to buy in.
Everything we know about the Compass IPO, plus information on how to buy in.
Everything we know about the Marqeta IPO, plus information on how to buy in.
Everything we know about the Pharming Group N.V. IPO, plus information on how to buy in.
Everything we know about the Metromile IPO, plus information on how to buy in.
Everything we know about the CN Energy Group IPO, plus information on how to buy in.
Everything we know about the Huadi International Group IPO, plus information on how to buy in.
Everything we know about the 908 Devices IPO, plus information on how to buy in.
Steps to owning and managing LEGH, with 24-hour and historical pricing before you buy.
Steps to owning and managing LAKE, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.